Congenital disorders of lung full details for md exam answer 15 marks
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Reading File
I now have comprehensive information from multiple authoritative textbooks. Let me compile the full 15-mark MD exam answer.
Congenital Disorders of the Lung
Introduction
Congenital lung disorders are a heterogeneous group of developmental anomalies arising from abnormal embryogenesis of the lung bud, tracheobronchial tree, pulmonary vasculature, or pulmonary parenchyma. They occur at a combined incidence of approximately 1 in 10,000 to 35,000 pregnancies. Many are now detected antenatally by routine ultrasound between 18 and 20 weeks of gestation. Severity ranges from asymptomatic incidental findings to neonatal respiratory failure and fetal hydrops.
Classification
Congenital lung disorders are broadly grouped as:
- Congenital Pulmonary Airway Malformation (CPAM) - previously CCAM
- Bronchopulmonary Sequestration (BPS)
- Congenital Lobar Emphysema (CLE)
- Bronchogenic Cysts
- Pulmonary Agenesis / Aplasia / Hypoplasia
- Bronchial Atresia
- Pulmonary Arteriovenous Malformations (PAVMs)
1. Congenital Pulmonary Airway Malformation (CPAM)
Definition and Pathogenesis
CPAM (previously called congenital cystic adenomatoid malformation / CCAM) is characterized by cystic hamartomatous lesions arising from abnormal branching of primitive bronchioles with arrested development at various stages of lung morphogenesis. The primary insult occurs during the pseudoglandular stage (weeks 5-17) but can extend to the alveolarization stage. Overexpression of Hoxb5, KGF/Fgf7, and PDGFB genes has been implicated in pathogenesis. Prevalence: 9 per 100,000 total births.
- Fishman's Pulmonary Diseases and Disorders, p. 1862
Stocker Classification (5 Types)
| Type | Origin | Cyst Size | Frequency | Key Features |
|---|---|---|---|---|
| Type 0 | Trachea / primary bronchus | Acinar dysplasia | Rare | Lethal; incompatible with life |
| Type 1 | Distal bronchus | Large (3-10 cm) single or few cysts | 50-70% | Most common; mass effect on adjacent organs |
| Type 2 | Terminal bronchioles | Small, evenly spaced (1-2 cm) | 15-30% | Associated with renal agenesis, cardiac defects, GI atresia, skeletal abnormalities |
| Type 3 | Bronchiolar / alveolar | Micro-cysts (<5 mm) | Rare | Appears solid on CT; cuboidal epithelium |
| Type 4 | Alveolar tissue | Very large peripheral cysts (up to 10 cm) | Rare | Risk of pneumothorax; indistinguishable from Type 1 on imaging |
Clinical Presentation
- Up to 50% of neonates are asymptomatic at birth
- May present with respiratory distress, recurrent pneumonias, or be detected incidentally
- Fetal hydrops develops in up to 40% without intervention - carries high mortality
- Adults may present with recurrent LRTI, aspergilloma, or spontaneous pneumothorax
Diagnosis
- Antenatal: Obstetric ultrasound (sensitivity 93%, specificity 32%); fetal MRI superior for distinguishing CPAM from BPS
- CCAM Volume Ratio (CVR): Volume of CPAM (as ellipse) / head circumference
- CVR >1.6 = >3% risk of hydrops (indication for maternal steroids)
- CVR <1.6 = <3% risk
- Postnatal: HRCT chest - cystic lesion(s) with mural nodules; air communication on expiratory HRCT
Malignant Potential
- Type 1 CPAM: Precursor to mucinous adenocarcinoma (via K-ras mutations in atypical goblet cells; chromosomal aberrations in chr 2 and 4)
- Type 2 CPAM: Associated with rhabdomyosarcoma and pleuropulmonary blastoma
- Type 4 CPAM: Associated with pleuropulmonary blastoma
Management
- Fetal hydrops + microcystic CPAM: Maternal corticosteroids (betamethasone) - can reverse hydrops
- Macrocystic CPAM with hydrops: Thoracoamniotic shunt placement (reverses hydrops); cyst aspiration (rapid but fluid reaccumulates)
- Open fetal surgery: For previable fetus (<30 weeks) with refractory hydrops
- EXIT procedure: For >30 weeks gestation
- Postnatal: Elective surgical resection (lobectomy via VATS) within 10 months of birth - associated with fewer complications
- Asymptomatic adults: Conservative with interval CT surveillance for Types 1 and 4
2. Bronchopulmonary Sequestration (BPS)
Definition
BPS is a mass of non-functioning lung tissue that has no communication with the tracheobronchial tree and derives its blood supply from systemic vessels (thoracic aorta 75%, abdominal aorta 25%). It is the second most common congenital pulmonary malformation, accounting for up to 6.4% of all cases.
- Fishman's Pulmonary Diseases and Disorders, p. 1863
Types: Intralobar vs Extralobar
| Feature | Intralobar BPS (ILS) | Extralobar BPS (ELS) |
|---|---|---|
| Frequency | 75% | 25% |
| Pleural covering | Shares pleura with normal lung | Has its own visceral pleura |
| Common location | Left lower lobe (60%), right lower lobe (38%) | Left hemithorax (48%), subdiaphragmatic (18%) |
| Venous drainage | Pulmonary or systemic | Always systemic |
| Infection | Recurrent LRTI (71%) | Less common (31%) |
| Association with CPAM | Less common | More common (up to 50% - Type 2 CPAM) |
| Other anomalies | Uncommon | 65% have associated malformations |
| Origin | Before pleural formation (or acquired post-infection) | After pleural formation |
Clinical Features
- Mostly asymptomatic at birth; undiagnosed until adolescence/adulthood
- Recurrent pneumonias - hallmark presentation in adults
- Up to 50% of adults found incidentally on thoracic imaging
Diagnosis
- Prenatal: Solid, homogeneous, hyperechoic mass on ultrasound; color Doppler identifies systemic feeding artery
- Postnatal: CT angiography (MDCT) is the gold standard - demonstrates consolidation/mass (often left lower hemithorax) with a systemic feeding artery
- MRI: Solid, well-defined, T2 hyperintense mass with systemic artery
- CXR: Homogeneous opacity at lung base
Management
- Asymptomatic, small: Conservative management
- Symptomatic or large: Surgical resection (lobectomy for ILS; simple excision for ELS) - VATS between 6-12 months postnatal life
- Adults: Resection for recurrent infections
- Antenatal: Fetal laser ablation of feeding artery (resolution in 92% of cases in small series); useful for lesions with hydrops or effusions
3. Congenital Lobar Emphysema (CLE)
Definition and Pathogenesis
CLE (also called Congenital Lobar Overinflation) is a rare disorder characterized by overdistension of a focal segment or lobe due to a check-valve mechanism causing progressive air trapping. Incidence: 1 in 20,000 live births; more common in males; accounts for 10.5% of all developmental lung disorders.
- Fishman's Pulmonary Diseases and Disorders, p. 1864
Pathogenic mechanisms:
- Focal cartilage defect - absent/deficient bronchial cartilage causes dynamic airway collapse and air trapping (25% of cases)
- Polyalveolar theory (Hislop and Reid, 1970) - fivefold increase in normal alveoli without overdistension initially; represents "alveolar giantism"
- Extrinsic bronchial compression from bronchogenic cyst, pulmonary artery sling, or vascular anomalies
Lobes Affected (in order)
- Left upper lobe (42%) - most common
- Right middle lobe (35%)
- Right upper lobe
- Bilateral rare
Clinical Features
- Neonatal respiratory distress with hyperresonance and decreased breath sounds over the affected lobe
- Mediastinal shift toward the contralateral side
- Mimics tension pneumothorax
Diagnosis
- CXR: Immediately postnatal - radio-opacity (lobe still fluid-filled); later - hyperlucency and overexpansion with mediastinal shift and contralateral compression
- CT chest: Overinflation with decreased vascularity, mediastinal shift
- Differential: Tension pneumothorax, bronchial atresia, CPAM Type 4
Management
- Conservative: For mild cases without significant respiratory distress (20-30% resolve spontaneously)
- Surgical: Lobectomy for severe respiratory distress; VATS approach preferred
4. Bronchogenic Cysts
Definition and Pathogenesis
Bronchogenic cysts are congenital anomalies derived from the lung bud of the foregut during embryonal lung development. They are fluid-filled blind cystic pouches. Location depends on timing of embryonic insult:
- Early defect → Mediastinal cysts (paratracheal, subcarinal, paraesophageal, hilar)
- Late defect → Intrapulmonary cysts (predominantly lower lobes)
Incidence: 1 in 42,000 to 68,000 hospital admissions; male predilection.
- Fishman's Pulmonary Diseases and Disorders, p. 1861
Clinical Features
- Often asymptomatic
- Symptoms from compression: SVC syndrome, dyspnoea, dysphagia
- Infection occurs in 82% of intrapulmonary cysts: persistent cough, purulent expectoration, haemoptysis, recurrent fever, chest pain
- Postobstructive pneumonia
Diagnosis
- CXR: Ovoid parenchymal/mediastinal mass with sharp borders; air-fluid level resembling lung abscess
- CT chest (gold standard): Fluid density (Hounsfield units variable - water to soft tissue); may contain "milk of calcium" (calcium precipitate); no contrast enhancement
- MRI: Variable T1 signal (proteinaceous debris); high T2 signal
Differential diagnosis:
- Mediastinal: Hydatid cyst (septations), cystic teratoma (fat, anterior mediastinum)
- Intrapulmonary: Infected bulla, lung abscess, tuberculous cavity, vascular malformation
Histopathology (definitive): Respiratory ciliated pseudostratified columnar epithelium with bronchial glands, smooth muscle, and cartilage in cyst wall
Management
- Asymptomatic: Conservative; mediastinoscopy or TBNA for diagnosis if needed
- Symptomatic: Surgical resection (thoracoscopic cystectomy or lobectomy if infected)
5. Pulmonary Agenesis, Aplasia, and Hypoplasia
Three categories grouped under the "agenesis-hypoplasia complex" with similar radiological findings:
| Entity | Definition |
|---|---|
| Pulmonary agenesis | Complete absence of lung parenchyma, bronchus, and pulmonary vasculature |
| Pulmonary aplasia | Blind-ending rudimentary bronchus, without lung parenchyma or pulmonary vasculature |
| Pulmonary hypoplasia | Rudimentary lung and bronchus with airways, alveoli, and pulmonary vessels decreased in number and size |
- Grainger & Allison's Diagnostic Radiology, p. 1779
Causes of secondary hypoplasia:
- Congenital diaphragmatic hernia (CDH) - most common intrathoracic cause
- Large CPAM or BPS compressing developing lung
- Severe oligohydramnios (Potter sequence) from genitourinary anomalies
- Skeletal dysplasia with small thorax
Radiology: CXR shows diffuse increased opacity of hemithorax, mediastinal shift, contralateral hyperinflation. CT/MRI differentiates the three entities.
Associations: Cardiovascular, GI, genitourinary, and skeletal congenital anomalies.
6. Bronchial Atresia
Congenital obliteration of a subsegmental, segmental, or lobar bronchus. Most commonly in the left upper lobe.
Pathophysiology: Air enters the affected lobe via collateral channels (Kohn's pores) causing overinflation and air trapping. Mucus accumulates in the atretic bronchus forming a mucocele.
Imaging: CXR/CT shows:
- Pulmonary overinflation with air trapping on expiratory views
- Central tubular, branched, or spherical opacity (mucocele)
Course: Often asymptomatic; infection rare; may progressively improve.
7. Pulmonary Arteriovenous Malformations (PAVMs)
Definition
Direct pulmonary artery-to-pulmonary vein connections causing right-to-left shunting. Usually congenital or arising in the context of Hereditary Hemorrhagic Telangiectasia (HHT) - an autosomal dominant disorder. 40-50% of HHT patients have pulmonary AVMs.
- Murray & Nadel's Textbook of Respiratory Medicine, p. 1663
Clinical Features
- Dyspnoea, platypnoea (breathlessness worse on standing)
- Cyanosis, clubbing, polycythaemia (right-to-left shunt)
- Paradoxical emboli: stroke, brain abscess
- Haemoptysis (rupture)
- Epistaxis and mucocutaneous telangiectasias (HHT)
Diagnosis
- CXR: Round/oval opacity, typically lower lobe
- CT angiography: Feeding artery + draining vein
- Contrast echocardiography (bubble study): Delayed appearance of bubbles in left heart (>3-5 cycles) confirms right-to-left shunting
Management
- Transcatheter coil/plug embolization: Treatment of choice
- Surgical resection: For large or multiple lesions not amenable to embolization
Summary Table: Key Differences
| Feature | CPAM | BPS | CLE | Bronchogenic Cyst |
|---|---|---|---|---|
| Airway connection | Yes (abnormal) | None | Yes | None |
| Blood supply | Pulmonary | Systemic | Pulmonary | Normal |
| Typical location | Any lobe | Lower lobe (left) | Left upper lobe | Mediastinum / lower lobe |
| Cystic/Solid | Cystic | Solid | Overinflated (gas) | Fluid cyst |
| Malignant risk | Yes (Types 1, 2, 4) | No | No | Rare |
| Common treatment | Lobectomy | Lobectomy/excision | Lobectomy | Cystectomy |
Key Points for MD Exam
- CVR >1.6 in CPAM is an indication for maternal steroid administration; it predicts hydrops risk >3%
- CPAM Type 1 carries risk of mucinous adenocarcinoma; Type 2 of rhabdomyosarcoma and pleuropulmonary blastoma
- Intralobar BPS has no separate pleura, drains to pulmonary veins, and gets recurrent infections; extralobar BPS has its own pleura, drains to systemic veins, and is associated with other anomalies (65%)
- Thoracoamniotic shunting is used for macrocystic CPAM or BPS with hydrops; maternal steroids work best for microcystic CPAM
- Congenital lobar emphysema: left upper lobe most common (42%); male predominance; presents as neonatal respiratory distress mimicking tension pneumothorax
- Bronchogenic cyst: histology shows ciliated pseudostratified columnar epithelium with cartilage, bronchial glands, and smooth muscle in the wall
- Hybrid lesions (combined BPS + CPAM features) exist and are important to recognize on imaging
- PAVMs: treat with embolization; paradoxical emboli causing stroke or brain abscess are the most serious complications
- Postnatal surgical resection of CPAM within 10 months of birth is associated with fewer complications
- MDCT angiography is the imaging modality of choice for all developmental lung lesions in children
Sources: Fishman's Pulmonary Diseases and Disorders (2-Volume Set); Murray & Nadel's Textbook of Respiratory Medicine; Sabiston Textbook of Surgery; Mulholland & Greenfield's Surgery; Grainger & Allison's Diagnostic Radiology
This is a shared conversation. Sign in to Orris to start your own chat.